5531 - 5540 of 7877 Results
Title
Year
- Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity2018OPENTitle: Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0049-1Best OA location URL: https://www.nature.com/articles/s41531-018-0049-1.pdfCitation Count: 64
- Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD2018RESTRICTEDTitle: Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PDJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 89Issue #: 9Start Page: 989End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2018-318060Citation Count: 60
-
OPENTitle: Testing a longitudinal compensation model in premanifest Huntington’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 7Start Page: 2156End Page: 2166Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awy122Best OA location URL: https://academic.oup.com/brain/article-pdf/141/7/2156/25094716/awy122.pdfCitation Count: 36
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048Citation Count: 3
- Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity2018OPENTitle: Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivityJournal Name: Journal of Psychosomatic ResearchPublisher: Elsevier BVVol: 112Issue #:Start Page: 32End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychores.2018.04.002Best OA location URL: https://cris.maastrichtuniversity.nl/files/60087405/Handels_2018_cognitive_behavioural_therapy_for_anxiety.pdfCitation Count: 14
- Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056)2018RESTRICTEDTitle: Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p2.056Citation Count: 0
-
OPENTitle: Pleiotropic Effects of Variants in Dementia Genes in Parkinson DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2018.00230Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2018.00230/pdfCitation Count: 22
-
OPENTitle: Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulationJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 390Issue #:Start Page: 33End Page: 35Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.04.002Best OA location URL: https://zenodo.org/records/3873091/files/Main_text_JONS_revised_26_Mar_2018_CLEAN.pdfCitation Count: 2